Table 2.
Day 20 – LT TNA | Day 200 – LT TNA | Day 200 – Ricin TNA | |||||||
---|---|---|---|---|---|---|---|---|---|
Group | Total | (A)a | (B) | Total | (A) | (B) | Total | (A) | (B) |
RiVax | 1b | (1) | (1) | 1 | (1) | (1) | 459 | (528) | (400) |
DNI | 1087 | (1213) | (951) | 1728 | (1600) | (1903) | 1 | (1) | (1) |
Dual | 205 | (264) | (159) | 800 | (606) | (1056) | 429 | (696) | (264) |
, Each group of mice (left column) was arbitrarily divided into two subsets, A and B. Shown are the neutralizing titers from sera collected on day 20 or 200 from the all mice in a group (as “Total”) or as the specific A and B subsets;
, mice lacking detectable toxin-neutralizing serum antibody titers were arbitrarily assigned a value of 1 for the purpose of statistical analysis.